13 unchanged sentences
Common Stock Performance
−Removed: The graph below shows the cumulative total return assuming an investment of $100 on December 31, 2018, in each of the Company’s Common Stock, the Standard & Poor’s, or S&P 500 Index and the S&P 500 Health Care Index, and assuming that all dividends were reinvested.
−Removed: For the purpose of this graph, the distribution of 100% of the outstanding Common Stock of Fortrea Holdings Inc.
−Removed: (Fortrea) to the Company's shareholders, pursuant to which Fortrea became an independent company, is treated as a non-taxable cash dividend of $33.11 per share, an amount equal to the opening price of Fortrea Common Stock when it began trading on June 20, 2023, that was deemed reinvested in the Company’s Common Stock at the closing price on June 20, 2023.
+Added: The graph below shows the cumulative total return assuming an investment of $100 on December 31, 2019, in each of the Company’s Common Stock, the Standard & Poor’s, (S&P) 500 Index and the S&P 500 Health Care Index, and assuming that all dividends were reinvested.
+Added: For the purpose of this graph, the distribution of 100% of the outstanding Common Stock of Fortrea to the Company’s shareholders, pursuant to which Fortrea became an independent company, is treated as a non-taxable cash dividend of $33.11 per share, an amount equal to the opening price of Fortrea common stock when it began trading on June 20, 2023, that was deemed reinvested in the Company’s Common Stock at the closing price on June 20, 2023.
Comparison of Cumulative Total Return
12/2019 12/2020 12/2021 12/2022 12/2023 12/2024
−Removed: Laboratory Corporation of America Holdings $ 100.00 $ 133.88 $ 161.09 $ 248.66 $ 187.97 $ 213.97
+Added: Labcorp Holdings Inc.
+Added: $ 100.00 $ 120.32 $ 185.74 $ 140.40 $ 159.82 $ 163.37
S&P 500 Index $ 100.00 $ 118.40 $ 152.39 $ 124.79 $ 157.59 $ 197.02
10 unchanged sentences
Remaining amounts are recognized as a reduction in retained earnings.
−Removed: At the end of 2023, the Company had outstanding authorization from the Board to purchase up to $530.4 of the Company's Common Stock.
+Added: At the end of 2024, the Company had outstanding authorization from its Board to purchase up to $1,280.4 maximum value of the Company’s Common Stock.
The repurchase authorization has no expiration date.
During the year ended December 31, 2023, the Company purchased 4.8 shares of its Common Stock at an average price per share of $206.85 for a total cost of $1,000.0.
−Removed: When the Company repurchases shares, the amount paid to repurchase the shares in excess of the par or stated value is allocated to additional paid-in-capital unless subject to limitation or the balance in additional paid-in-capital is exhausted.
−Removed: Remaining amounts are recognized as a reduction in retained earnings.
−Removed: SELECTED FINANCIAL DATA
−Removed: Not applicable.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.